Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® HSV specialty page provides HSV-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

HSV NEWS - Page 1

HSV-2 Prevention Measures Could Be Important Tool in Ending HIV Epidemic
Existing evidence has suggested a strong biological link between HIV and herpes simplex virus 2 infection.
Prime and Pull: An Innovative Approach to HSV-2 Vaccine Development
The first step (prime) is to immunize with conventional vaccines through a needle in the arm. The second step (pull), is to apply an antibiotic cream that helps attract, T cells, to the site of virus growth.
Herpes Vaccine HSV529 Shows Favorable Results in Phase 1 Trial
In the first-in-human trial of the replication-defective HSV529, the vaccine was well-tolerated and elicited antibody and T-cell responses in HSV seronegative adults.
VOICE Trial: Daily Vaginal Tenofovir Gel Use Reduced Genital Herpes Risk in Women
A new study finds that regular use of tenofovir gel helped reduce the risk of genital herpes acquisition in women in sub-Saharan Africa.
 
Abandoned Genital Herpes Vaccine GEN-003 Found to Reduce Lesions, Decrease Viral Shedding at Varying Doses
Varying dose levels of the GEN-003 vaccine were found to be associated with decreased viral shedding and lesion reduction at up to 1 year post-treatment.
Molecule May Offer New Potential Treatment Option for Resistant Ocular HSV
A molecule capable of clearing HSV-1 infection in the cells of the cornea could be a promising potential option for those who have developed resistance to current drugs.
<i>Contagion</i>®'s Top 10 Infectious Disease Articles of 2017
Check out the top 10 infectious disease articles of 2017.
Tenofovir, Used to Combat HIV, Also Acts on Herpes
Scientists are working on developing preventive and therapeutic strategies that target both HIV and herpes, as having herpes may make individuals more vulnerable to contracting HIV.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?